United States: Inching Toward Harmonization: FDA Finalizes Rule On IRB Waiver Of Informed Consent For Minimal Risk Studies - Ropes & Gray LLP

Credit: Mondaq- Published on February 23, 2024

On December 21, 2023, the U.S. Food and Drug Administration ("FDA") published a final rule to allow institutional review boards ("IRBs") to waive or alter informed consent for certain clinical...